GlobeNewswire - News from California Contains the last 20 releases uuid:6f78be9b-876c-4b27-bbef-4dce6ea70e17;id=13657 2021-02-06T00:51:18Z newsdesk@globenewswire.com (NewsDesk) http://www.10gbhost.com/LegacyRss?Length=4 newsdesk@globenewswire.com http://www.10gbhost.com/news-release/2021/02/06/2170949/0/en/CareTrust-REIT-Sets-Fourth-Quarter-Earnings-Call-for-Thursday-February-11-2021.html CareTrust REIT Sets Fourth Quarter Earnings Call for Thursday, February 11, 2021 2021-02-06T00:51:18Z 2021-02-06T02:26:17Z SAN CLEMENTE, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- CareTrust REIT, Inc. (NASDAQ:CTRE) announced today that it plans to release its fourth quarter and full year 2020 financial results after the U.S. markets close on Wednesday, February 10, 2021. Representatives of CareTrust REIT’s management team will host a conference call to discuss the results and other current matters the following day.

]]>
2170949 en GlobeNewswire Inc. CareTrust REIT, Inc. Sat, 06 Feb 2021 00:51 GMT Calendar of Events Healthcare REAL ESTATE REITs skilled nursing Seniors Housing
http://www.10gbhost.com/news-release/2021/02/05/2170934/0/en/Equillium-Announces-Closing-of-30-Million-Registered-Direct-Offering.html Equillium Announces Closing of $30 Million Registered Direct Offering 2021-02-05T22:36:08Z 2021-02-06T02:26:17Z LA JOLLA, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced the closing of its previously announced registered direct offering with life science institutional investment funds managed by Decheng Capital, to purchase 4,285,710 units (the “Units”) from Equillium, with each Unit consisting of one share of common stock and a warrant to purchase 0.3 of a share of common stock. The purchase price per Unit was $7.00, priced above the market under Nasdaq rules. The warrants have an exercise price of $14.00 per share, are immediately exercisable, and will expire on the earlier of (i) the fifth anniversary of issuance, or (ii) the 15th calendar date following the date on which Equillium closes a financing raising a minimum of $25 million at a price per share of no less than $25.00.? ?

]]>
2170934 en GlobeNewswire Inc. Equillium, Inc. Fri, 05 Feb 2021 22:36 GMT Stock Market News
http://www.10gbhost.com/news-release/2021/02/05/2170927/0/en/Pacific-Biosciences-Grants-Equity-Incentive-Award-to-New-Employee.html Pacific Biosciences Grants Equity Incentive Award to New Employee 2021-02-05T22:00:00Z 2021-02-06T02:26:17Z MENLO PARK, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of Pacific Biosciences common stock and restricted stock units (“RSU”) covering 50,000 shares of Pacific Biosciences common stock to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan on December 14, 2020 (the “2020 Inducement Plan”).

]]>
2170927 en GlobeNewswire Inc. Pacific Biosciences of California, Inc. Fri, 05 Feb 2021 22:00 GMT Product / Services Announcement Stock Market News
http://www.10gbhost.com/news-release/2021/02/05/2170929/0/en/Assembly-Biosciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2021-02-05T22:00:00Z 2021-02-06T02:26:17Z SOUTH SAN FRANCISCO, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced grants of stock options to three new employees to purchase an aggregate of 38,000 shares of the Company’s common stock with an exercise price of $5.79 per share, the closing price of Assembly Bio’s common stock on February 1, 2021. The stock options were granted as material inducements to the new employees to accept the Company’s offers of employment.

]]>
2170929 en GlobeNewswire Inc. Assembly Biosciences, Inc. Fri, 05 Feb 2021 22:00 GMT Company Announcement
http://www.10gbhost.com/news-release/2021/02/05/2170925/0/en/BridgeBio-Pharma-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 2021-02-05T21:30:00Z 2021-02-06T02:26:17Z PALO ALTO, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases, today announced that on February 1, 2021, the compensation committee of BridgeBio’s board of directors granted 11 new employees restricted stock units for an aggregate of 16,772 shares of the Company’s common stock. All of the above-described awards were made under BridgeBio’s 2019 Inducement Equity Plan (the Plan).

]]>
2170925 en GlobeNewswire Inc. BridgeBio Pharma, Inc. Fri, 05 Feb 2021 21:30 GMT Changes in company's own shares
http://www.10gbhost.com/news-release/2021/02/05/2170910/0/en/Prothena-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 2021-02-05T21:05:00Z 2021-02-06T02:26:17Z DUBLIN, Ireland, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid and?neurodegenerative diseases, today announced that in connection with hiring three new employees, the compensation committee of the Company’s board of directors granted the individuals hired by the Company, in the aggregate, options to purchase 75,000 ordinary shares of the Company. The options have an exercise price per share equal to $11.00, which was the closing trading price on February 1, 2021, the date of the grants. The inducement awards will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the date of grants and 1/48th of the underlying shares vesting monthly thereafter over 36 months. The options were granted pursuant to the Company’s 2020 Employment Inducement Incentive Plan, which was approved by the Company’s board of directors under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.

]]>
2170910 en GlobeNewswire Inc. Prothena Corporation plc Fri, 05 Feb 2021 21:05 GMT Stock Market News
http://www.10gbhost.com/news-release/2021/02/05/2170911/0/en/SeaSpine-Reports-Granting-of-Inducement-Awards.html SeaSpine Reports Granting of Inducement Awards 2021-02-05T21:05:00Z 2021-02-06T02:26:17Z CARLSBAD, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to nine non-executive employees.

]]>
2170911 en GlobeNewswire Inc. SeaSpine Holdings Corporation Fri, 05 Feb 2021 21:05 GMT Stock Market News
http://www.10gbhost.com/news-release/2021/02/05/2170901/0/en/HAGENS-BERMAN-National-Trial-Attorneys-Alerts-Triterras-TRIT-Investors-to-Fast-Approaching-Deadline-Investors-with-Significant-Losses-Should-Contact-Firm.html HAGENS BERMAN, National Trial Attorneys, Alerts Triterras (TRIT) Investors to Fast Approaching Deadline, Investors with Significant Losses Should Contact Firm 2021-02-05T20:22:21Z 2021-02-06T02:26:17Z SAN FRANCISCO, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Triterras, Inc. (NASDAQ: TRIT) investors with significant losses to submit your losses now. A securities fraud class action has been filed and certain investors may have valuable claims.

]]>
2170901 en GlobeNewswire Inc. Hagens Berman Sobol Shapiro LLP Fri, 05 Feb 2021 20:22 GMT Class Action Law & Legal Issues TRIT class action TRIT lawsuit TRIT securities class action TRIT securities fraud TRIT investor TRIT shareholder TRIT stock Class Action
http://www.10gbhost.com/news-release/2021/02/05/2170900/0/en/CLOV-INVESTOR-ALERT-Clover-Health-Investments-CLOV-Investors-Urged-to-Contact-HAGENS-BERMAN-National-Trial-Attorneys-CLOV-Admits-Prior-Knowledge-of-Undisclosed-DOJ-Inquiry-Announce.html CLOV INVESTOR ALERT: Clover Health Investments (CLOV) Investors Urged to Contact HAGENS BERMAN, National Trial Attorneys; CLOV Admits Prior Knowledge of Undisclosed DOJ Inquiry & Announces Receipt of SEC Inquiry into Potential Securities Fraud 2021-02-05T20:17:49Z 2021-02-06T02:26:17Z SAN FRANCISCO, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Hagens Berman encourages Clover Health Investments, Corp. (NASDAQ: CLOV) investors to submit their losses now.?The firm is investigating possible securities fraud and certain investors may have valuable claims.

]]>
2170900 en GlobeNewswire Inc. Hagens Berman Sobol Shapiro LLP Fri, 05 Feb 2021 20:18 GMT Class Action Law & Legal Issues CLOV investigation CLOV investor CLOV securities CLOV fraud CLOV securities fraud CLOV investor fraud CLOV stock Class Action
http://www.10gbhost.com/news-release/2021/02/05/2170883/0/en/End-of-Day-Message.html End of Day Message 2021-02-05T18:35:00Z 2021-02-06T02:26:17Z LONDON, 05 Feb. 2021 (GLOBE NEWSWIRE) -- This is the End of Day Message for GlobeNewswire.

]]>
2170883 en GlobeNewswire Inc. GlobeNewswire UK Regulatory Daily Messages Fri, 05 Feb 2021 18:35 GMT Company Announcement European Regulatory News
http://www.10gbhost.com/news-release/2021/02/05/2170878/0/en/June-5-Cobra-Day-To-Bring-Largest-Display-of-Shelby-Cobras-in-Over-30-Years.html June 5 “Cobra Day” To Bring Largest Display of Shelby Cobras in Over 30 Years 2021-02-05T18:15:00Z 2021-02-06T02:26:17Z Martinez, CA event features sweepstakes to win a rare 50th Anniversary Shelby 289 FIA Cobra Roadster]]> 2170878 en GlobeNewswire Inc. DJEK Inc. dba The Cobra Experience Fri, 05 Feb 2021 18:15 GMT Calendar of Events Auto Show Martinez California Shelby Cobra Drawing Win a Cobra Enter to Win a Shelby Cobra Shelby Cobra Sweepstakes http://www.10gbhost.com/news-release/2021/02/05/2170877/0/en/DUE-TO-OVERWHELMING-SUPPORT-FROM-THE-DOGECOIN-COMMUNITY-KRONOS-WILL-MANUFACTURE-ONE-THOUSAND-OF-OUR-AIRDOG-PURIFIRS-REBRANDED-AS-AIRDOGE-AS-A-NUMBERED-LIMITED-EDITION.html DUE TO OVERWHELMING SUPPORT FROM THE DOGECOIN COMMUNITY, KRONOS WILL MANUFACTURE ONE THOUSAND OF OUR AIRDOG PURIFIRS REBRANDED AS “AIRDOGE” AS A NUMBERED, LIMITED EDITION. 2021-02-05T18:12:46Z 2021-02-06T02:26:17Z Los Angeles, CA, Feb. 05, 2021 (GLOBE NEWSWIRE) -- LOS ANGELES, CA, February 5, 2021 (GLOBE NEWSWIRE) -- KRONOS ADVANCED TECHNOLOGIES, INC., (OTC MARKETS: KNOS) ("KNOS" or the "Company"), a revenue-generating, product development and production company that has significantly changed the way air is moved, filtered and sterilized reports today the release of a limited-edition air purifier due to an overwhelming, positive response from Reddit's Dogecoin community. This vibrant community showed tremendous support for our decision to add DOGE coin as an additional form of payment for our products, along with other major cryptocurrencies, such as Bitcoin, Ethereum, and Litecoin. We believe that part of this enthusiasm, in addition to the great need for our products, is due to Kronos becoming the first publicly traded Company to announce the acceptance of the DOGE coin.

]]>
2170877 en GlobeNewswire Inc. Kronos Advanced Technologies Inc. Fri, 05 Feb 2021 18:12 GMT Exchange News Feature Article Company Announcement Health Press releases
http://www.10gbhost.com/news-release/2021/02/05/2170874/0/en/KNDI-4-DAY-INVESTOR-DEADLINE-Hagens-Berman-Alerts-Kandi-Technologies-Group-KNDI-Investors-to-February-9th-Deadline-in-Securities-Fraud-Lawsuit-Investors-with-Losses-Should-Contact-.html KNDI 4-DAY INVESTOR DEADLINE: Hagens Berman Alerts Kandi Technologies Group (KNDI) Investors to February 9th Deadline in Securities Fraud Lawsuit, Investors with Losses Should Contact the Firm Now 2021-02-05T17:56:25Z 2021-02-06T02:26:17Z SAN FRANCISCO, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Kandi Technologies Group, Inc. (NASDAQ: KNDI) investors to submit their losses now. A securities fraud class action has been filed and certain investors may have valuable claims.

]]>
2170874 en GlobeNewswire Inc. Hagens Berman Sobol Shapiro LLP Fri, 05 Feb 2021 17:56 GMT Class Action Law & Legal Issues KNDI class action KNDI fraud KNDI lawsuit KNDI securities KNDI investor fraud KNDI stock KNDI securities class action Class Action
http://www.10gbhost.com/news-release/2021/02/05/2170870/0/en/The-Roddenberry-Foundation-Donates-100-000-to-the-Comic-Con-Museum.html The Roddenberry Foundation Donates $100,000 to the Comic-Con Museum 2021-02-05T17:27:07Z 2021-02-06T02:26:17Z Funding supports the Museum’s renovation and programming plans in anticipation of the 2021 opening of its physical space in San Diego; also recognizes the Museum’s efforts to highlight inclusivity, innovation and creativity while honoring the legacy of Star Trek creator Gene Roddenberry]]> 2170870 en GlobeNewswire Inc. Comic-Con Museum Fri, 05 Feb 2021 17:27 GMT Arts & Entertainment Company Announcement Press releases Comic-Con Museum Roddenberry Foundation Donation Star Trek Museum Non-Profit http://www.10gbhost.com/news-release/2021/02/05/2170829/0/en/Glancy-Prongay-Murray-LLP-Reminds-Investors-of-Looming-Deadline-in-the-Class-Action-Lawsuit-Against-9F-Inc-JFU.html Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against 9F Inc. (JFU) 2021-02-05T16:00:00Z 2021-02-06T02:26:17Z LOS ANGELES, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming?March 22, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased or otherwise acquired 9F Inc. (“9F” or the “Company”) (NASDAQ: JFU) securities: (a) pursuant and/or traceable to the registration statement and related prospectus in connection with the Company’s August 14, 2019 initial public offering (the “IPO” or “Offering”); and/or (b) between August 14, 2019 and September 29, 2020, inclusive (the “Class Period”).

]]>
2170829 en GlobeNewswire Inc. Glancy Prongay & Murray LLP Fri, 05 Feb 2021 16:00 GMT Class Action Law & Legal Issues #JFU #securitieslitigation #reminder #LEADPLAINTIFFDEADLINE #classaction #shareholders #investors #stocks Class Action
http://www.10gbhost.com/news-release/2021/02/05/2170830/0/en/Glancy-Prongay-Murray-LLP-Reminds-Investors-of-Looming-Deadline-in-the-Class-Action-Lawsuit-Against-Lizhi-Inc-LIZI.html Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lizhi, Inc. (LIZI) 2021-02-05T16:00:00Z 2021-02-06T02:26:17Z LOS ANGELES, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming?March 22, 2021?deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Lizhi Inc. (“Lizhi” or the “Company”) (NASDAQ: LIZI) American Depositary Shares (“ADSs” or “shares”) pursuant and/or traceable to the Company’s January 2020 initial public offering (“IPO” or the “Offering”).

]]>
2170830 en GlobeNewswire Inc. Glancy Prongay & Murray LLP Fri, 05 Feb 2021 16:00 GMT Class Action Law & Legal Issues #LIZI #stocks #investors #shareholders #classaction #LEADPLAINTIFFDEADLINE #reminder #securitieslitigation Class Action
http://www.10gbhost.com/news-release/2021/02/05/2170739/0/en/Denali-Therapeutics-to-Present-New-Data-on-ETV-IDS-DNL310-for-the-Potential-Treatment-of-Hunter-Syndrome-at-WORLDSymposium.html Denali Therapeutics to Present New Data on ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at WORLDSymposium? 2021-02-05T14:00:00Z 2021-02-06T02:26:17Z – Management to host webinar for analysts on Friday, Feb. 12, at 8:00 a.m. Eastern Time –]]> 2170739 en GlobeNewswire Inc. Denali Therapeutics Inc. Fri, 05 Feb 2021 14:00 GMT Calendar of Events Health biotechnology Biotech Neurodegeneration clinical trials Denali Therapeutics Hunter Syndrome MPSII blood-brain barrier http://www.10gbhost.com/news-release/2021/02/05/2170732/0/en/PDF-Solutions-to-Report-Fourth-Quarter-and-Fiscal-Year-2020-Financial-Results-on-February-18-2021.html PDF Solutions to Report Fourth Quarter and Fiscal Year 2020 Financial Results on February 18, 2021 2021-02-05T13:59:07Z 2021-02-06T02:26:17Z SAN JOSE, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of smart manufacturing analytics and connectivity platforms for the semiconductor and electronics industries, announced that it?will release fourth quarter and fiscal year 2020 financial results after the market close on Thursday, February 18, 2021. John Kibarian, CEO, and Adnan Raza, CFO, will host a live teleconference on February 18, 2021, beginning at 2:00?p.m. Pacific Time / 5:00?p.m. Eastern Time to discuss the results. To?participate on?the call, please dial (877) 221-5831?within the United States and Canada, or?(706) 902-1220?outside of the United States and Canada.?You do not need a passcode, just reference the "PDF Solutions' Fourth Quarter and Fiscal Year 2020 Financial Results Call.” ?The teleconference will be webcast simultaneously on the company’s website at?http://ir.pdf.com/webcasts.

]]>
2170732 en GlobeNewswire Inc. PDF Solutions, Inc. Fri, 05 Feb 2021 13:59 GMT Calendar of Events
http://www.10gbhost.com/news-release/2021/02/05/2170706/0/en/Angion-Biomedica-Corp-Announces-Pricing-of-Initial-Public-Offering-of-Common-Stock-and-Concurrent-Private-Placement.html Angion Biomedica Corp. Announces Pricing of Initial Public Offering of Common Stock and Concurrent Private Placement 2021-02-05T13:30:00Z 2021-02-06T02:26:17Z UNIONDALE, N.Y., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (Angion) (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases, today announced the pricing of its initial public offering on February 4, 2021 of 5,000,000 shares of common stock at a public offering price of $16.00 per share, for gross proceeds of $80,000,000 million, before deducting the underwriting discounts and commissions and offering expenses. All of the shares of common stock are being offered by Angion. Angion has also granted the underwriters a 30-day option to purchase from Angion up to an additional 750,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions. Angion’s common stock has been approved for listing on The Nasdaq Global Select Market and is expected to begin trading under the ticker symbol “ANGN” on February 5, 2021. The offering is expected to close on February 9, 2021, subject to satisfaction of customary closing conditions.

]]>
2170706 en GlobeNewswire Inc. Angion Biomedica Corp. Fri, 05 Feb 2021 13:30 GMT Initial Public Offerings Stock Market News Changes in company's own shares IPO Initial Public Offering San Francisco Boston New York kidney lung transplant
http://www.10gbhost.com/news-release/2021/02/05/2170697/0/en/Oncocyte-Announces-Pricing-of-35-Million-Public-Offering-of-Common-Stock.html Oncocyte Announces Pricing of $35 Million Public Offering of Common Stock 2021-02-05T13:25:00Z 2021-02-06T02:26:17Z IRVINE, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it has priced the previously announced underwritten public offering of 7,780,000 shares of its common stock, at a public offering price of?$4.50?per share. The gross proceeds to the Company from this offering are expected to be approximately?$35.0 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. The offering is expected to close on or about?February 9, 2021, subject to satisfaction of customary closing conditions. The Company has granted the underwriters a 30-day option to purchase up to an additional 1,167,000 shares of its common stock at the public offering price.

]]>
2170697 en GlobeNewswire Inc. Oncocyte Corporation Fri, 05 Feb 2021 13:25 GMT Stock Market News
亚洲精品私拍国产在线播放_亚洲综合区图片小说区_亚洲日本欧美日韩高观看